Sort
35,931 grants matching “parkinsons”
Structure and function of the mouse parafasicular and entopeduncular nuclei
$391,652Bernardo L Sabatini · Harvard Medical School · R01 · FY2017 · NS
GI Endotoxin as an Environmental Trigger in an alpha-Synuclein Transgenic Mouse
$391,644Robert L Nussbaum · University Of California, San Francisco · R01 · FY2010 · ES
Synaptic and circuit mechanisms of compensation following loss of cone inputs in themature mouse retina
$391,638Felice A Dunn · University Of California, San Francisco · R01 · FY2022 · EY
Adrenergic transmission properties and implication
$391,638Mark Beenhakker · University Of Virginia · R01 · FY2024 · NS
Striatal Mechanisms of Dyskinesia and Impulse Control in Parkinsonâs Disease
$391,638Alexandra Nelson · University Of California, San Francisco · R01 · FY2024 · NS
Mechanisms of renin-angiotensin signaling in programmed and insult-induced neuronal death
$391,637Su Guo · University Of California, San Francisco · R01 · FY2024 · NS
Synaptic and circuit mechanisms of compensation following loss of cone inputs in themature mouse retina
$391,637Felice A Dunn · University Of California, San Francisco · R01 · FY2021 · EY
Pathophysiology of dystonia: animal models
$391,625Ellen J. Hess · Emory University · R01 · FY2009 · NS
Urate-LRRK2 interactions in Parkinson's disease
$391,611Michael A Schwarzschild · Massachusetts General Hospital · R01 · FY2021 · NS
Mapping neural ensemble computations to biological circuitry in motor control and decision making - Resubmission - 1
$391,599Matthew Tyler Kaufman · University Of Chicago · R01 · FY2021 · NS
Manufacturing of Trojan Horse-TNFR Decoy Receptor Fusion Protein
$391,592Ruben J. Boado · Armagen Technologies, Inc. · R44 · FY2013 · AG
NOVEL THERAPEUTIC APPROACHES FOR PARKINSON'S DISEASE
$391,551Mc Lean Hospital (Belmont, Ma) · P50 · FY2004 · NS
Genetic Epidemiology of HAD Susceptibility Genes
$391,511Sunil K Ahuja · University Of Texas Hlth Science Center · R01 · FY2007 · MH
Neuroprotective mechanism of DJ-1 in Parkinson's disease
$391,493Un Jung Kang · University Of Chicago · R01 · FY2010 · NS
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
$391,431Richard J. Barohn · University Of Kansas Medical Center · R01 · FY2015 · FD
Neuron death in Parkinson's disease: The role of Trib3
$391,388Lloyd A Greene · Columbia University Health Sciences · R01 · FY2020 · NS
Neuron death in Parkinson's disease: The role of Trib3
$391,387Lloyd A Greene · Columbia University Health Sciences · R01 · FY2019 · NS
Neuron death in Parkinson's disease: The role of Trib3
$391,387Lloyd A Greene · Columbia University Health Sciences · R01 · FY2021 · NS
Neuron death in Parkinson's disease: The role of Trib3
$391,387Lloyd A Greene · Columbia University Health Sciences · R01 · FY2022 · NS
Neuron death in Parkinson's disease: The role of Trib3
$391,387Lloyd A Greene · Columbia University Health Sciences · R01 · FY2018 · NS
Network Models for Timing and Sequence Generation
$391,369Laurence F. Abbott · Columbia University Health Sciences · R01 · FY2011 · MH
Exploiting new fibril structures to understand the biophysical basis for oligomerization and toxicity of alpha-Synuclein
$391,364Jonathan N Sachs · University Of Minnesota · R01 · FY2021 · NS
PDRemote: Automated Telehealth Diagnostics for Remote Parkinson's Monitoring
$391,358Joseph Giuffrida · Great Lakes Neurotechnologies · R44 · FY2013 · MD
Neurotoxicity of nanomaterials: evaluation of subcellular redox state
$391,312Gary W Miller · Emory University · R01 · FY2010 · ES
Connexins in Neuronal and Glial Gap Junctions in the Central Nervous System
$391,274John E Rash · Colorado State University · R01 · FY2008 · NS